Twitter Beğeni Hilesi

ACHD affects over 2.4 million in the U.S. and 1 in 13 will develop HF. Despite the morbidity/mortality of HF there is more limited evidence for GDMT. SOTA review on GDMT in ACHD-HF in #HREV (link.springer.com/article/10.100…). Steve Greene Shahzeb Khan Josephine Harrington, MD Jennifer Ting

Wilfried Mullens Congratulations. Great study.

It’s not too late to register for a brand new meeting packaged with HFSA sessions in Atlanta! Marat Fudim, MD MHS and Liviu Klein and others have built a program encouraging you to literally get your hands on device therapies for heart failure! Don’t get FOMO!

We are proud to announce the first patient enrollment today at Saint Luke's Mid America Heart Institute for the fourth and final clinical trial (FINALITY-HF) of the larger MOONRAKER program on finerenone in heart failure. FINEARTS-HF, the first in the finerenone program,

It is fitting to have this primer on upfront combination therapy in HFpEF from Steve Greene and Robert Mentz, MD out in #HREV (link.springer.com/article/10.100…) ahead of FINEARTS presentation at ESC. Growing therapeutic options! Muthu Vaduganathan Andrew J Sauer MD Mikhail Kosiborod

🚨­­ MAJOR news in the #ATTR #amyloidosis world! Today the ­­­much-anticipated HELIOS-B results were presented European Society of Cardiology & simultaneously published in NEJM. The largest ATTR-CM trial published to date, testing #vutrisiran vs. placebo. Bottom line: Huge win for vutrisiran!

🔥 Fresh presentation at #ESC 2024 European Society of Cardiology 🔥 🔥 Fresh publication in JACC Journals 🔥 Our work on this secondary analysis of: #TRILUMINATE Impact of Renal & Liver Function on Clinical Outcomes Following Tricuspid Valve Transcatheter Edge-to-Edge Repair | Journal of the

More content coming out to support European Society of Cardiology #ESC2024 presentations for Day #3. Looking forward to #FINEARTSHF and discussions on emerging role of nonsteroidal #MRA for HFmrEF/HFpEF Stay tuned for more JACC Journals content to supplement discussion. Link is below.

#FINEARTSHF HFmrEF/HFpEF population Finerenone vs placebo Reduced primary endpoint (CVD / HF events) Looking forward to ongoing subsequent trials and analyses.

🔥 A new therapeutic era in #HFpEF #FINEARTSHF with definitive evidence supporting the role of the non-steroidal MRA finerenone at #ESCCongress Now in NEJM nejm.org/doi/full/10.10…

Tour de force of MRAs in HF across the EF spectrum to coincide with FINEARTS-HF. Led by Andrew J Sauer MD!

Stay tuned for a very special episode of #DontMissABeat coming soon from #ESCCongress. Discussing all things #finerenone and #FINEARTS_HF. A deep dive into the latest therapeutic milestone for #HF and the practical implications for our patients. Muthu Vaduganathan #GDMTworks

In #FINEARTS-HF Trial finererone significantly reduced CV Death & HF Events in HFmr/pEF population compared to placebo. European Society of Cardiology #ESCCongress2024 #MOONRAKER Andrew J Sauer MD Mikhail Kosiborod Marc Bonaca MD MPH CPC Clinical Research nejm.org/doi/full/10.10…

Time for polygenics & #precision medicine is here. Our study presented at #ESC2024 JOHN GORDON HAROLD, MD, MACC, MACP, FRCP, FRCPI John Kastelein Christopher Kramer MD Nathan Wong Biljana Parapid, MD, PhD, FESC

In the wake of the highly successful European Society of Cardiology #ESC2024 that saw the publication of many important RCTs, it bears mentioning that observational data are good for describing practice patterns, not for treatment comparisons.

Super review on mineralocorticoid receptor antagonists and the evidence to support their use in #heartfailure across the #LVEF continuum Andrew J Sauer MD jacc.org/doi/10.1016/j.… #MRA #steroidalMRA #nonsteroidalMRA

HFSA announces late-breaking research for 2024 annual meeting Check out: HuMAIN, FINEARTS, STEP HFpEF And I’ll be presenting CARE-HK in HF ⁦Mikhail Kosiborod⁩ ⁦Steve Greene⁩ cardiovascularbusiness.com/topics/profess…

On the latest episode of the Don't Miss a Beat podcast, DCRI’s Steve Greene joined his cohost and FINEARTS-HF investigator Muthu Vaduganathan to discuss finerenone in treatment algorithms for heart failure at #ESCCongress: hcplive.com/view/dont-miss…

Great SoTA review on digital health innovations to boost patient engagement in self-care and GDMT adherence for HF. Congrats to Alex Sandhu and team on this timely work! (link.springer.com/article/10.100…) #HREV Steve Greene Marat Fudim, MD MHS Ankeet S. Bhatt, MD, MBA AJ Blood, MD, MS

🔥🔥🔥 An essential resource! Outstanding review on steroidal versus nonsteroidal MRA in HF. All trials, mechanisms, profiles. Andrew J Sauer MD Harriette Van Spall, MD MPH Andrew P. Ambrosy, MD #JACCHF JACC Journals jacc.org/doi/10.1016/j.…